A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

Clinical trial NCT06381739 · RECRUITING

Trial details

NCT number: NCT06381739
Sponsor: McMaster University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Infection

Start date: 2025-03-25
Primary completion: 2026-12-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.